In July 2025, I had the opportunity to speak to GPs in Torbay about osteoporosis—a condition where bones become fragile and more likely to break. My talk focused on the latest developments in understanding bone health, particularly the arrival of new anabolic (bone-building) treatments.
Traditionally, most osteoporosis medicines have worked by slowing down bone loss. While these remain very effective, new anabolic therapies work differently: they stimulate the body to actively build new bone. This means they don’t just prevent further weakening but can actually help to restore strength to fragile bones.
For people at highest risk of fractures—such as those who have already broken a hip or spine bone—starting with an anabolic treatment and then moving on to a “maintenance” medicine is proving to be a powerful approach. This sequential treatment strategy helps reduce the risk of further fractures and keeps bones stronger for longer.
I also emphasised the importance of lifestyle measures alongside medication: weight-bearing exercise, a healthy diet with enough calcium and vitamin D, and fall prevention.
These advances are offering new hope. With better treatments and earlier diagnosis, osteoporosis can be managed more effectively than ever before.